May 10, 2016
A group of CPCB researchers, PhD alums Drs. Armaghan Naik, Joshua Kangas, Devin Sullivan, and their advisor, Dr. Robert F. Murphy have created the first robotically driven experimentation system to determine the effects of a large number of drugs on many proteins, reducing the number of necessary experiments by 70%. The model, presented in elife, uses an approach that could lead to accurate predictions of the interactions between novel drugs and their targets, helping reduce the cost of drug discovery.
CPCB group’s robotically driven experimentation system could reduce the cost of discovering drug and target interactions
A group of CPCB researchers, PhD alums Drs. Armaghan Naik, Joshua Kangas, Devin Sullivan, and their advisor, Dr. Robert F. Murphy have created the first robotically driven experimentation system to determine the effects of a large number of drugs on many proteins, reducing the number of necessary experiments by 70%. The model, presented in elife, uses an approach that could lead to accurate predictions of the interactions between novel drugs and their targets, helping reduce the cost of drug discovery.